Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for perioperative neuroprotection in children with congenital heart disease undergoing cardiac surgery
ChiCTR1900028593Phase 4Recruiting
- Sponsor
- Fuwai Hospital
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in Cardiovascular Malformation (CVM) (2 arms), sponsored by Fuwai Hospital. Primary endpoints: Perioperative serum or plasma S100beta concentration and Perioperative serum or plasma neuron-specific enolase concentration. Started Jun 2018; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ChiCTR1900028593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028593.